Immunotech Biopharm Ltd (HKG:6978)
Hong Kong
· Delayed Price · Currency is HKD 2.990
-0.010 (-0.33%)
Jun 24, 2025, 11:40 AM HKT
Immunotech Biopharm Market Cap
Immunotech Biopharm has a market cap or net worth of 1.54 billion as of June 23, 2025. Its market cap has increased by 1.69% in one year.
Market Cap
1.54B
Enterprise Value
1.89B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.99
Market Cap Chart
Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 1.54B, a decrease of -80.05%. That is a compound annual growth rate of -27.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2025 | 1.54B | 30.43% |
| Dec 31, 2024 | 1.18B | -54.00% |
| Dec 29, 2023 | 2.57B | 7.99% |
| Dec 30, 2022 | 2.38B | -72.51% |
| Dec 31, 2021 | 8.67B | 50.90% |
| Dec 31, 2020 | 5.74B | -25.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 230.13B |
| Hansoh Pharmaceutical Group Company | 170.05B |
| Innovent Biologics | 130.31B |
| JD Health International | 127.04B |
| WuXi Biologics | 99.68B |
| Sino Biopharmaceutical | 92.28B |
| CSPC Pharmaceutical Group | 88.12B |
| Akeso | 85.45B |